article thumbnail

Next-Generation Sequencing (NGS) Markets, 2026 by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), & Application (Diagnostic, Drug Discovery, Agriculture) – ResearchAndMarkets.com

BioTech 365

Next-Generation Sequencing (NGS) Markets, 2026 by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), & Application (Diagnostic, Drug Discovery, Agriculture) – ResearchAndMarkets.com Next-Generation Sequencing (NGS) Markets, 2026 by Product & Service (Consumables, Platforms, Services, Bioinformatics), (..)

article thumbnail

M2GEN partners with Zephyr AI to identify treatments for cancer patients

Pharmaceutical Technology

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. It will use the machine learning platform from Zephyr AI and a real-world data set (RWD) from M2GEN for creating an oncology discovery product.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Start-up hopes to boost production of viral vectors for ATMPs

Drug Discovery World

The company’s DNA-based platform is being developed to address manufacturing challenges associated with the production of recombinant adeno-associated virus (rAAV) vectors used to produce advanced therapy medicinal products (ATMPs).

article thumbnail

NSF backs bioinformatics approach to understanding plant RNA modifications

Scienmag

Led by Boyce Thompson Institute’s Andrew Nelson, four partners will identify RNA modifications and develop resources that may lead to hardier crops Credit: Photo credit: Anna Nelson Dittrich ITHACA, NY, August 4, 2020 — RNA perform a variety of functions in cells, helping with everything from regulating genes to building proteins.

RNA 74
article thumbnail

Exclusive event on using adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

article thumbnail

Learn how to use adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

article thumbnail

A guide to using adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.